Altered-fractionated radiotherapy in locally advanced head and neck cancer

Current Opinion in Oncology

Volumn 24, Issue 3, 2012, Pages 223-228

  Bernier, Jacques ^a   Horiot, Jean Claude ^a  

^a Genolier Swiss Medical Network SA   (Switzerland)

Author keywords

chemo radiotherapy; fractionation; head and neck; intensity modulated radiation therapy; locally advanced

Indexed keywords

CISPLATIN; NIMORAZOLE;

ADVANCED CANCER; ALTERED FRACTIONATED RADIOTHERAPY; CANCER RADIOTHERAPY; FRACTIONATION; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; HUMAN; HYPERFRACTIONATION; LARYNX CARCINOMA; MULTIPLE CYCLE TREATMENT; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; REVIEW; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS AS TOPIC; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY, INTENSITY-MODULATED; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84859835291     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0b013e32834ea6fe     Document Type: Review

References (30)

1. Marcu LG. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain. Cancer Treat Rev 2010; 36:606-614.
2. Steel GG. The radiobiology of human tumour cells. Br J Radiol Suppl 1988; 22:116-120.
3. Thames HD Jr, Withers HR, Peters LJ, Fletcher GH. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys 1982; 8:219-226. (Pubitemid 12139897)
4. Thames HD Jr, Withers HR. Test of equal effect per fraction and estimation of initial clonogen number in microcolony assays of survival after fractionated irradiation. Br J Radiol 1980; 53:1071-1077. (Pubitemid 10024329)
5. Thames HD, Bentzen SM, Turesson I, et al. Fractionation parameters for human tissues and tumors. Int J Radiat Biol 1989; 56:701-710. (Pubitemid 20002017)
6. Keefe DM, Rassias G, O'Neil L, Gibson RJ. Severe mucositis: how can nutrition help? Curr Opin Clin Nutr Metab Care 2007; 10:627-631. (Pubitemid 47254726)
7. Horiot JC, Bontemps P, van den BogaertW, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997; 44:111-121. (Pubitemid 27345198)
8. Horiot JC, Le Fur R, N'Guyen T, et al. Hyperfractionated compared with conventional radiotherapy in oropharyngeal carcinoma: an EORTC randomized trial. Eur J Cancer 1990; 26:779-780. (Pubitemid 20328546)
9. Bentzen SM, Saunders MI, Dische S. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. Radiother Oncol 1999; 53:219-226.
10. Overgaard J, Hansen HS, Specht L, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003; 362:933-940. (Pubitemid 37159288)
11. Ang KK, Peters LJ, Weber RS, et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 1990; 19:1339-1345.
12. Fu KK, Pajak TF, Trotti A, et al. Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48:7-16. (Pubitemid 30488207)
13. Studer G, Huguenin PU, Davis JB, et al. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients. Radiat Oncol 2006; 31:7.
14. Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 2000; 46:619-630. (Pubitemid 30100639)
15. Hartley A, Sanghera P, Kazi W, et al. Correlation of currently used radiobiological parameters with local control and acute and late mucosal toxicity in randomised studies of altered fractionation for locally advanced head and neck cancer. Clin Oncol (R Coll Radiol) 2011; 23:29-33.
16. Bourhis J, Overgaard J, Audry H, et al. On behalf of Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006; 368:843-854.
17. Budach W, Hehr T, Budach V, et al. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 2006; 6:28.
18. Baujat B, Bourhis J, Blanchard P, et al. Hyperfractionated or accelerated radiotherapy for head and neck cancer. Cochrane Database Syst Rev 2010; CD002026.
19. Saunders MI, Rojas AM, Parmar MK, Dische S. CHART Trial Collaborators. Mature results of a randomized trial of accelerated hyperfractionated versus conventional radiotherapy in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010; 77:3-8.
20. Bernier J, Domenge C, Ozsahin M, et al. European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350:1945-1952. (Pubitemid 38580197)
21. Bernier J. Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology? Nat Clin Pract Oncol 2005; 2:305-314. (Pubitemid 40903175)
22. Ang K, Zhang Q, Wheeler RH, et al. A phase III trial (RTOG 0129) of two radiation-cisplatin regimens for head and neck carcinomas (HNC): impact of radiation and cisplatin intensity on outcome [Abstract]. J Clin Oncol 2010; 28 (Suppl 15):A-5507.
23. Garden AS, Harris J, Trotti A, et al. Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14). Int J Radiat Oncol Biol Phys 2008; 71:1351-1355. (Pubitemid 351978166)
24. Chung CH, Gillison ML. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res 2009; 15:6758-6762.
25. Bhide SA, Nutting CM. Recent advances in radiotherapy. BMC Med 2010; 8:25.
26. Ho KF, Fowler JF, Sykes AJ, et al. IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficult. Acta Oncol 2009; 48:431-439.
27. Allen AM, Wolfsberger L, Tishler RB, Court LE. Options for combining altered fractionation with IMRT. Technol Cancer Res Treat 2008; 7:457-561.
28. Chakraborty S, Ghoshal S, Patil VM, et al. Preliminary results of SIB-IMRT in head and neck cancers: report from a regional cancer center in northern India. J Cancer Res Ther 2009; 5:165-172.
29. Rosenthal DI, Trotti A. Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol 2009; 19:29-34.
30. Bourhis J, Lapeyre M, Tortochaux J, et al. Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. J Clin Oncol 2006; 24:2873-2878. (Pubitemid 46630588)